• LAST PRICE
    0.0250
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0250
  • Day Range
    ---
  • 52 Week Range
    Low 0.0050
    High 0.0250
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSGTI
Shengtai Pharmaceutical Inc
239.6K
0.0x
---
United StatesSHWZ
Medicine Man Technologies Inc
52.2M
-2.3x
---
United StatesTXMD
TherapeuticsMD Inc
81.1M
-0.4x
---
United StatesLTUS
Lotus Pharmaceuticals Inc
33.1M
0.2x
+42.39%
United StatesEGRX
Eagle Pharmaceuticals Inc
444.4M
12.9x
---
United StatesUPC
Universe Pharmaceuticals Inc
14.3M
1.1x
---
As of 2022-08-13

Company Information

Shengtai Pharmaceutical, Inc. (Shengtai), through its wholly owned subsidiary, Weifang Shengtai Pharmaceutical Inc., is a producer of pharmaceutical-grade glucose in China. The Company's products include pharmaceutical-grade glucose or dextrose, used for medical purposes, as well as other glucose and cornstarch products used for the food and beverage industry, and for industrial productions in China. The Company's glucose series include dextrose monohydrate (DMH), dextrose anhydrous, oral glucose dextrin and rough glucose for other processing purposes. Its starch series include pharmaceutical starch and edible corn starch. The Company's customers include healthcare institutions, food and beverage companies, pharmaceutical companies, medical supply exporters and medical supply. The Company also exports its products to approximately 70 different countries overseas, such as Japan, Singapore, Korea, Australia, Russia and India.

Contact Information

Headquarters
Development District Changle County,, Changda Road East,WEIFANG, SDG, China 262400
Phone
536-218-2777
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Qingtai Liu
Chief Financial Officer, Director
Yongqiang Wang
Independent Director
Tao Jin
Independent Director
Lawrence Lee
Independent Director
Yaojun Liu

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$239.6K
Revenue (TTM)
---
Shares Outstanding
9.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
---
Book Value
$6.50
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.